SP1 and ovarian carcinoma: Therefore, we hypothesize that the cytotoxic effects of 6RK73 in ovarian cancer cells may occur through a UCHL1-independent mechanism, potentially involving suppression of the AKT1/Sp1/c-Myc signaling axis.